|
[212Pb]Pb-MP0712 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: [212Pb]Pb-DOTAM-MAM279
Omaha, Nebraska1 trial
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Nebraska Cancer Specialists
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.